Nkarta, Inc. Debt Securities, Available-for-sale, Realized Gain (Loss)
Nkarta, Inc. (NKTX) reported Debt Securities, Available-for-sale, Realized Gain (Loss) of $94.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss · last filed 2026-08-10
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-12-31 was $51.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-09-30 was $8.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-06-30 was $35.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for the quarter ending 2025-03-31 was $0.00.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2025 was $94.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2023 was $34.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2022 was -$490.00K.
- Nkarta, Inc. debt securities, available-for-sale, realized gain (loss) for fiscal 2020 was $0.00.
| Period end | Debt Securities, Available-for-sale, Realized Gain (Loss) 3 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 6 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 9 month | Debt Securities, Available-for-sale, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $59.00K derived: sum of 2 quarters · filed 2026-03-25 | $94.00K derived: sum of 3 quarters · filed 2026-08-10 | $94.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $43.00K derived: sum of 2 quarters · filed 2026-08-10 | $43.00K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $35.00K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $0.00 10-Q · filed 2026-05-12 | |||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $0.00 10-Q · filed 2025-11-10 | $0.00 derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $0.00 10-Q · filed 2025-08-12 | $0.00 derived: sum of 3 quarters · filed 2025-08-12 | $0.00 derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $0.00 derived: sum of 4 quarters · filed 2025-03-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $0.00 derived: sum of 2 quarters · filed 2025-03-26 | $0.00 derived: sum of 3 quarters · filed 2025-03-26 | $34.00K 10-K · filed 2025-03-26 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $34.00K 10-Q · filed 2024-11-07 | -$456.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $34.00K 10-Q · filed 2024-08-13 | -$456.00K derived: sum of 3 quarters · filed 2024-08-13 | -$456.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $34.00K 10-Q · filed 2024-05-09 | -$456.00K derived: sum of 2 quarters · filed 2024-05-09 | -$456.00K derived: sum of 3 quarters · filed 2024-05-09 | -$456.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$490.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$490.00K derived: sum of 2 quarters · filed 2024-03-21 | -$490.00K derived: sum of 3 quarters · filed 2024-03-21 | -$490.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | |||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $0.00 derived: sum of 4 quarters · filed 2021-11-10 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | $0.00 derived: sum of 3 quarters · filed 2021-05-13 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 10-K · filed 2021-03-25 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |